209 related articles for article (PubMed ID: 21426147)
1. Observations on screening-based research and some concerning trends in the literature.
Baell JB
Future Med Chem; 2010 Oct; 2(10):1529-46. PubMed ID: 21426147
[TBL] [Abstract][Full Text] [Related]
2. Fragonomics: fragment-based drug discovery.
Zartler ER; Shapiro MJ
Curr Opin Chem Biol; 2005 Aug; 9(4):366-70. PubMed ID: 15925537
[TBL] [Abstract][Full Text] [Related]
3. Fragment-based activity space: smaller is better.
Hesterkamp T; Whittaker M
Curr Opin Chem Biol; 2008 Jun; 12(3):260-8. PubMed ID: 18316043
[TBL] [Abstract][Full Text] [Related]
4. Molecular diversity in the context of leadlikeness: compound properties that enable effective biochemical screening.
Rishton GM
Curr Opin Chem Biol; 2008 Jun; 12(3):340-51. PubMed ID: 18328272
[TBL] [Abstract][Full Text] [Related]
5. Unfinished business: target-based drug discovery.
Brown D
Drug Discov Today; 2007 Dec; 12(23-24):1007-12. PubMed ID: 18061878
[TBL] [Abstract][Full Text] [Related]
6. Obtaining exposures of metabolites in preclinical species through plasma pooling and quantitative NMR: addressing metabolites in safety testing (MIST) guidance without using radiolabeled compounds and chemically synthesized metabolite standards.
Vishwanathan K; Babalola K; Wang J; Espina R; Yu L; Adedoyin A; Talaat R; Mutlib A; Scatina J
Chem Res Toxicol; 2009 Feb; 22(2):311-22. PubMed ID: 19067650
[TBL] [Abstract][Full Text] [Related]
7. Targeted scoring functions for virtual screening.
Seifert MH
Drug Discov Today; 2009 Jun; 14(11-12):562-9. PubMed ID: 19508918
[TBL] [Abstract][Full Text] [Related]
8. From fragment to clinical candidate--a historical perspective.
Chessari G; Woodhead AJ
Drug Discov Today; 2009 Jul; 14(13-14):668-75. PubMed ID: 19427404
[TBL] [Abstract][Full Text] [Related]
9. Structure-guided fragment screening for lead discovery.
Verdonk ML; Hartshorn MJ
Curr Opin Drug Discov Devel; 2004 Jul; 7(4):404-10. PubMed ID: 15338949
[TBL] [Abstract][Full Text] [Related]
10. Mitigating permeability-mediated risks in drug discovery.
Wang J; Skolnik S
Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):171-87. PubMed ID: 20064074
[TBL] [Abstract][Full Text] [Related]
11. Label-free screening assays: a strategy for finding better drug candidates.
Lunn CA
Future Med Chem; 2010 Nov; 2(11):1703-16. PubMed ID: 21428840
[TBL] [Abstract][Full Text] [Related]
12. [Strategy of molecular drug design: hits, leads and drug candidates].
Guo ZR
Yao Xue Xue Bao; 2008 Sep; 43(9):898-904. PubMed ID: 19048779
[TBL] [Abstract][Full Text] [Related]
13. How to avoid rediscovering the known.
Kuo LC
Methods Enzymol; 2011; 493():159-68. PubMed ID: 21371591
[TBL] [Abstract][Full Text] [Related]
14. New roles for structure in biology and drug discovery.
Russell RB; Eggleston DS
Nat Struct Biol; 2000 Nov; 7 Suppl():928-30. PubMed ID: 11103989
[No Abstract] [Full Text] [Related]
15. Designing screens: how to make your hits a hit.
Walters WP; Namchuk M
Nat Rev Drug Discov; 2003 Apr; 2(4):259-66. PubMed ID: 12669025
[TBL] [Abstract][Full Text] [Related]
16. Correct assessment of new compounds using in vivo screening models can reduce false positives.
Bueters TJ; Hoogstraate J; Visser SA
Drug Discov Today; 2009 Jan; 14(1-2):89-94. PubMed ID: 18840543
[TBL] [Abstract][Full Text] [Related]
17. New screening tools for lead compound identification.
Sawyer TK
Nat Chem Biol; 2005 Aug; 1(3):125. PubMed ID: 16408012
[No Abstract] [Full Text] [Related]
18. The devil is still in the details--driving early drug discovery forward with biophysical experimental methods.
Lundqvist T
Curr Opin Drug Discov Devel; 2005 Jul; 8(4):513-9. PubMed ID: 16022188
[TBL] [Abstract][Full Text] [Related]
19. Model-based drug discovery: implementation and impact.
Visser SA; Aurell M; Jones RD; Schuck VJ; Egnell AC; Peters SA; Brynne L; Yates JW; Jansson-Löfmark R; Tan B; Cooke M; Barry ST; Hughes A; Bredberg U
Drug Discov Today; 2013 Aug; 18(15-16):764-75. PubMed ID: 23726890
[TBL] [Abstract][Full Text] [Related]
20. Affinity-based screening techniques for enhancing lead discovery.
Comess KM; Schurdak ME
Curr Opin Drug Discov Devel; 2004 Jul; 7(4):411-6. PubMed ID: 15338950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
